Skip to main content

Journal of Cancer Survivorship

Ausgabe 2/2023

Inhalt (25 Artikel)

Open Access

Trajectories of cognitive symptoms and associated factors in cancer survivors after return to work: an 18-month longitudinal cohort study

Johanna K. Ehrenstein, Sander K. R. van Zon, Saskia F. A. Duijts, Roy E. Stewart, Josué Almansa, Benjamin C. Amick III, Sanne B. Schagen, Ute Bültmann

Social risk factors among individuals with a history of cancer during the COVID-19 pandemic

Cheryl Kelly, Larissa Lee White, Shauna Goldberg Scott, Heather Spencer Feigelson, Andrea N. Burnett-Hartman

“Both a life saver and totally shameful”: young adult cancer survivors’ perceptions of medical crowdfunding

Lauren V. Ghazal, Samantha E. Watson, Brooke Gentry, Sheila J. Santacroce

Transition practices for survivors of childhood cancer: a report from the Children’s Oncology Group

Jordan Gilleland Marchak, Karim T. Sadak, Karen E. Effinger, Regine Haardörfer, Cam Escoffery, Karen E. Kinahan, David R. Freyer, Eric J. Chow, Ann Mertens

Cardiovascular disease prevention and management of pre-existent cardiovascular disease in a cohort of prostate cancer survivors

Aaron J. Katz, Ronald C. Chen, Deborah S. Usinger, Susanne M. Danus, Leah L. Zullig

Assessing the impact of religious resources and struggle on well-being: a report from the American Cancer Society’s Study of Cancer Survivors-I

Andrea L. Canada, Patricia E. Murphy, Kevin Stein, Kassandra I. Alcaraz, Corinne R. Leach, George Fitchett

Zur Zeit gratis COVID-19

Experiences of adolescent and young adult cancer survivors during the COVID-19 pandemic

Adam Yan, Kaitlyn Howden, Alyson L. Mahar, Ian Scott, Camille Glidden, Julie Deleemans, Karine Chalifour, Geoff Eaton, Abha Gupta, James M. Bolton, Sheila N. Garland, Sapna Oberoi

Review

Patient education for breast cancer–related lymphedema: a systematic review

Marisa Perdomo, Claire Davies, Kimberly Levenhagen, Kathryn Ryans, Laura Gilchrist

Review

The effects of physical exercise in the palliative care phase for people with advanced cancer: a systematic review with meta-analysis

Kellie Toohey, Michael Chapman, Anne-Marie Rushby, Kat Urban, Gemma Ingham, Benjamin Singh

Open Access

The role of general practitioners in the work guidance of cancer patients: views of general practitioners and occupational physicians

Marie-Christine Sarfo, Lucinda Bertels, Monique H. W. Frings-Dresen, Femke de Jong, Annette H. Blankenstein, Kristel M. van Asselt, Angela G. E. M. de Boer

Review

Factors influencing the e-health literacy in cancer patients: a systematic review

Yan Zhang, Peirong Xu, Qiannan Sun, Shantanu Baral, Lijuan Xi, Daorong Wang

Open Access

Survivorship care plans and information for rural cancer survivors

Arlen Rowe, Fiona Crawford-Williams, Belinda. C Goodwin, Larry Myers, Anna Stiller, Jeff Dunn, Joanne. F Aitken, Sonja March

The Affordable Care Act and suicide incidence among adults with cancer

Justin M. Barnes, Evan M. Graboyes, Eric Adjei Boakye, Erin E. Kent, Jeffrey F. Scherrer, Eliza M. Park, Donald L. Rosenstein, Yvonne M. Mowery, Junzo P. Chino, David M. Brizel, Nosayaba Osazuwa-Peters

Chronic pain and its correlates among long-term breast cancer survivors

Michelle Yin, Cong Wang, Kai Gu, Pingping Bao, Xiao-Ou Shu

Review

Return to work in head and neck cancer survivors: a systematic review

Claudia Zecena Morales, Karolina Lisy, Lachlan McDowell, Amanda Piper, Michael Jefford

Ambiguous loss in family caregivers of loved ones with cancer, a synthesis of qualitative studies

Charlotte R. Weiss, Christina Baker, Anne Gillespie, Jacqueline Jones

Open Access

Health behaviors, obesity, and marital status among cancer survivors: a MEPS study

Lixin Song, Ting Guan, Peiran Guo, Xianming Tan, Ashley Leak Bryant, William A. Wood, Anthony D. Sung, Erin Elizabeth Kent, Thomas C. Keyserling

Policy Paper

Implementing and sustaining a breast cancer prospective surveillance rehabilitation program: an institutional perspective

Nicole L. Stout, Ralph Utzman, Hannah Hazard Jenkins, Megan Burkart, Anne K. Swisher

Open Access

Educational pathways of childhood cancer survivors—a parental cohort

S. Michael, A. Borgmann-Staudt, G. Sommerhäuser, K. Kepakova, S. Klco-Brosius, J. Kruseova, E. Nagele, A. Panasiuk, J. Vetsch, M. Balcerek

Open Access

Body image concerns in long-term head and neck cancer survivors: prevalence and role of clinical factors and patient-reported late effects

Anna Ivanova, Rubén Rodríguez-Cano, Ingela Lundin Kvalem, Diana Harcourt, Cecilie E. Kiserud, Cecilie D. Amdal

Exercise adherence in a randomized controlled trial of exercise on quality of life in ovarian cancer survivors

Anlan Cao, Brenda Cartmel, Fang-Yong Li, Linda T. Gottlieb, Maura Harrigan, Jennifer A. Ligibel, Radhika Gogoi, Peter E. Schwartz, Melinda L. Irwin, Leah M. Ferrucci

Review

Evaluation of quality, readability, suitability, and usefulness of online resources available to cancer survivors

Lydia Rosa Bourdache, Lydia Ould Brahim, Sydney Wasserman, Marrah Nicolas-Joseph, Francesca Y. E. Frati, Eric Belzile, Sylvie D. Lambert

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.